搜索临床试验以:CXCR2转导的自体肿瘤浸润淋巴细胞
总计129个结果
-
Women's Hospital School Of Medicine Zhejiang UniversitySun Yat-sen University; Tongji Hospital; Qilu Hospital of Shandong University尚未招聘肿瘤浸润淋巴细胞
-
Hervor TherapeuticsCancer Institute and Hospital, Chinese Academy of Medical Sciences; Women's Hospital School... 和其他合作者招聘中
-
XinWu招聘中Metastatic or Recurrent Gynecological Tumors中国
-
CAR-T (Shanghai) Cell Biotechnology Co., Ltd.Eastern Hepatobiliary Surgery Hospital未知
-
Iovance Biotherapeutics, Inc.招聘中
-
University Hospital, Basel, SwitzerlandAnaveon AG招聘中
-
Shanghai Juncell Therapeutics尚未招聘乳腺癌 | 妇科肿瘤 | 肺癌 | 实体瘤 | 胃肠癌
-
Chinese PLA General Hospital未知复发性成人弥漫性大细胞淋巴瘤 | 复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 复发性套细胞淋巴瘤 | 造血/淋巴癌 | 缓解期成人急性淋巴细胞白血病 | B细胞慢性淋巴细胞白血病 | 幼淋巴细胞白血病 | 难治性慢性淋巴细胞白血病 | III 期成人弥漫性大细胞淋巴瘤 | III 期 1 级滤泡性淋巴瘤 | III 期 2 级滤泡性淋巴瘤 | III 期 3 级滤泡性淋巴瘤 | III 期套细胞淋巴瘤 | IV 期成人弥漫性大细胞淋巴瘤 | IV 期 1 级滤泡性淋巴瘤 | IV 期 2 级滤泡性淋巴瘤 | IV 期 3 级滤泡性淋巴瘤 | IV 期套细胞淋巴瘤 | B 细胞成人急性淋巴细胞白血病 | III期慢性淋巴细胞白血病 | IV 期慢性淋巴细胞白血病中国
-
Shanghai Juncell TherapeuticsSir Run Run Shaw Hospital招聘中
-
Shanghai Juncell TherapeuticsShanghai 10th People's Hospital招聘中
-
Shanghai Juncell TherapeuticsSecond Affiliated Hospital of Soochow University招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense招聘中
-
Shanghai Juncell TherapeuticsShanghai 10th People's Hospital招聘中
-
Shanghai Juncell TherapeuticsShanghai 10th People's Hospital招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)终止
-
Gregory DanielsImmunotherapy Foundation招聘中
-
University of FloridaBeat Childhood Cancer Research Consortium招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.主动,不招人恶性实体肿瘤 | 软组织肉瘤 | 复发性卵巢癌 | 三阴性乳腺癌 | 复发性骨肉瘤 | 难治性骨肉瘤 | 骨肉瘤 | 骨巨细胞瘤 | 卵巢癌肉瘤 | 铂类耐药卵巢癌 | 去分化软骨肉瘤 | 骨巨细胞瘤的恶性程度 | 低分化甲状腺癌 | 甲状腺间变性癌 | 甲状腺鳞状细胞癌 | 未分化高级别多形性骨肉瘤美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的